Join Us
We are a dedicated community of scientists advancing the field of medicine, alongside leaders in business and culture, changemakers and tastemakers, the curious, the generous, the trailblazers, and the kind.
Together, we are harnessing the brainpower and network of this community to drive progress in medicine and longevity.
For three days this Fall, DOC will transform the Fairmont Sonoma Mission Inn into an exclusive and intimate community gathering committed to scaling proven advances in longevity science and medicine. Passes for DOC 2026: Longevity Science & Medical AI are limited, and expected to sell out quickly.
Stay connected — subscribe to our monthly newsletter, The DOCUMENT.
All science, no bullsh*t
What is Doc and why should you care
Pioneering a New Era in Health(care)
DOC is a community of exceptional minds — physicians (MD), scientists (PhD), entrepreneurs, financiers, and artists — dedicated to transforming health at personal, professional, and societal levels.
Our mission is to unite and catalyze influential leaders across health, business, and culture to advance credible science, foster meaningful dialogue, and catalyze innovations that improve lives.
Featured Media
-
Longevity Science | DOC Welcomes Adam Gazzaley, M.D., Ph.D. to its 2026 Faculty
Neuroscientist Adam Gazzaley, M.D., Ph.D., founder of UCSF’s Neuroscape, joins DOC 2026 to share research on neuromodulation and video games that boost memory and attention.
Recommended
-
The DOC Poll: Off-label Peptides? Our Community Weighs In.
After the FDA panel’s peptide compounding vote, our August poll found only 8.3% of DOC members use peptides — most want real clinical trial data…
-
Longevity Science | William Peranteau, M.D. Joins DOC 2026 Faculty
William Peranteau, M.D., of Children’s Hospital of Philadelphia joins DOC 2026 Faculty to discuss pioneering in utero gene editing therapies treating genetic diseases before birth.
-
Longevity Science | Ruth Gimeno, Ph.D. Welcomed to DOC 2026 Faculty
Eli Lilly’s Ruth Gimeno, Ph.D. joins DOC 2026 Faculty to explore GLP-1 peptides, retatrutide, and cardiometabolic breakthroughs shaping obesity and diabetes treatment’s future.
Past EVENT ROUNDUP
The New DOCtrine
— Dr. Jordan Shlain
The energy at DOC 2025: The Science of Longevity was electric — the kind you feel when hundreds of people hungry for real answers gather in one space. And the feedback? No ego, all enthusiasm. Pure curiosity meeting hard science, no pretense required.
We covered ten topics, and if there’s a thread running through them all, it’s this: the future of healthcare isn’t waiting for permission. It’s happening in breath tests, wearable devices, disruptive AI systems, and in conversations that challenge what we’ve accepted as inevitable about aging.
Feedback